Cargando…
Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies
BACKGROUND: Antipsychotic agents (APS) are widely used drugs to treat psychotic symptoms and can effectively reduce both positive and negative symptoms of schizophrenia. For decades, some studies suggested that there is a relationship between using APS and the risk of venous thromboembolism (VTE) an...
Autores principales: | Liu, Yinzhao, Xu, Jun, Fang, Kacey, Xu, Yue, Gao, Ju, Zhou, Chao, Tang, Xiaowei, Fang, Xinyu, Chen, Jiu, Xie, Chunming, Zhang, Fuquan, Zhang, Xiangrong, Wang, Congjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812411/ https://www.ncbi.nlm.nih.gov/pubmed/33505665 http://dx.doi.org/10.1177/2045125320982720 |
Ejemplares similares
-
Association of the HTR2C-759C/T polymorphism and antipsychotic-induced weight gain: a meta-analysis
por: Chen, Yan, et al.
Publicado: (2020) -
Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis
por: Birdal, Oğuzhan, et al.
Publicado: (2023) -
Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies
por: Kunutsor, Setor K., et al.
Publicado: (2019) -
Risk of venous and arterial thromboembolic events associated with tyrosine kinase inhibitors in advanced thyroid cancer: a meta-analysis and systematic review
por: Bai, Yang, et al.
Publicado: (2018) -
Predictors and mortality risk of venous thromboembolism in patients
with COVID-19: systematic review and meta-analysis of observational
studies
por: Agarwal, Gaurav, et al.
Publicado: (2022)